Download PDF
Dtsch Med Wochenschr 2006; 131(21): 1223-1227
DOI: 10.1055/s-2006-941757
Aktuelle Diagnostik & Therapie | Review article
Angiologie
© Georg Thieme Verlag KG Stuttgart · New York

Raynaud-Phänomen - Aktuelle Diagnostik und Therapie

Current diagnostic and treatment of Raynaud’s phenomenonL. Caspary1 , A. Creutzig1
  • 1Angiologische Gemeinschaftspraxis und Gefäßzentrum am Klinikum Oststadt, Hannover
Further Information

Publication History

eingereicht: 6.3.2006

akzeptiert: 25.4.2006

Publication Date:
23 May 2006 (online)

Also available at
    Permissions and Reprints

Schlüsselwörter

Raynaud-Phänomen - akrale Vasospastik - Sklerodermie - Vibrationssyndrom

Key words

Raynaud’s phenomenon - digital vasospasm - scleroderma - vibration white finger syndrome

Literatur

  • 1 Anderson M E, Moore T L. et al . Digital vascular response to topical glyceryl trinitrate, as measured by laser Doppler imaging, in primary Raynaud’s phenomenon and systemic sclerosis.  Rheumatology. 2002;  41 324-328
    Google Scholar
  • 2 Appiah R, Hiller H, Caspary L, Creutzig A, Alexander K. Treatment of primary RaynaudŽs syndrome with traditional Chinese acupuncture.  J Intern Med. 1997;  241 119-124
    Google Scholar
  • 3 Boin F, Wigley F M. Understanding, assessing and treating Raynaud’s phenomenon.  Curr Opin Rheumatol. 2005;  17 752-760
    Google Scholar
  • 4 Bukhari M, Hollis S, Moore T, Jayson M IV, Herrick A L. Quantitation of microcircular abnormalities in patients with primary Raynaud’s phenomenon and systemic sclerosis by video capillaroscopy.  Rheumatology. 2000;  39 506-512
    Google Scholar
  • 5 Cazelets C, Cador B, Rolland Y. et al . Exploration de la microcirculation pulpaire par écho-Doppler digitale chez des patients présentant une maladie de Raynaud ou une sclérocermie.  J Mal Vasc. 2004;  29 12-20
    Google Scholar
  • 6 Coleiro B, Marshall S E, Denton C P. et al . Treatment of Raynaud’s phenomenon with the selective serotonin reuptake inhibitor fluoxetin.  Rheumatology. 2001;  40 1038-1043
    Google Scholar
  • 7 Creutzig A, Freund M, Caspary L, Alexander K. Microangiopathy in patients with chronic myelogenous leukemia treated with interferon.  Microvasc Res. 1996;  52 288-292
    Google Scholar
  • 8 Czupryniak A, Kaluzynska A, Nowicki M. et al . Raynaud’s Phenomenon and Endothelial Dysfunction in End-Stage Renal Disease Patients Treated with Hemodialysis.  Kidney Blood Press Res. 2005;  28 27-31
    Google Scholar
  • 9 Gemne G, Pyykkö I, Taylor W. et al . The Stockholm Workshop scale for the classification of cold-induced Raynaud’s phenomenon in the hand-arm vibration syndrome (revision of the Taylor-Pelmaer scale).  Scand J Work Environ Health. 1987;  13 275-278
    Google Scholar
  • 10 Marasini B, Massarotti M, Bottasso B. et al . Comparison between iloprost and alprostadil in the treatment of Raynaud’s phenomenon.  Scand J Rheumatol. 2004;  33 253-256
    Google Scholar
  • 11 Rosenkranz S, Caglayan E, Diet F. et al . Langzeiteffekte von Sildenafil bei Sklerodermie-assoziierter pulmonaler Hypertonie und Raynaud-Syndrom.  Dtsch Med Wochenschr. 2004;  129 1736-1740
    Google Scholar
  • 12 Thompson A E, Pope J E. Calcium channel blockers for primary Raynaud’s phenomenon: a meta-analysis.  Rheumatology. 2005;  44 145-150
    Google Scholar
  • 13 von Bierbrauer A, Schilk I, Lucke C, Schmidt J A. Infrared thermography in the diagnosis of Raynaud’s phenomenon in vibration-induced white finger.  Vasa. 1998;  27 94-99
    Google Scholar
  • 14 Wörnle M, Tatò F, Hoffmann U. Hypothenar-Hammer-Syndrom als Ursache einer schweren digitalen Ischämie.  Dtsch Med Wochenschr. 2004;  129 2352-2355
    Google Scholar
  • 15 Zandman-Goddard G, Tweezer-Zaks N, Shoenfeld Y. New therapeutic strategies for systemic sclerosis - a critical analysis of the literature.  Clin Dev Immunol. 2005;  12 165-173
    Google Scholar

Priv.-Doz. Dr. med. Ludwig Caspary

Angiologische Gemeinschaftspraxis

Luisenstraße 10/11

30159 Hannover

Phone: 0511/3681830

Fax: 0511/3681930

Email: LCaspary@t-online.de

      >